Processa Pharmaceuticals, Inc. Advertising Expense
Processa Pharmaceuticals, Inc. (PCSA) reported Advertising Expense of $135 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2018-04-16
- Processa Pharmaceuticals, Inc. advertising expense for fiscal 2017 was $135.00, a 96.49% decline from fiscal 2016.
- Processa Pharmaceuticals, Inc. advertising expense for fiscal 2016 was $3.85K, a 84.86% decline from fiscal 2015.
- Processa Pharmaceuticals, Inc. advertising expense for fiscal 2015 was $25.43K, a 77.77% decline from fiscal 2014.
- Processa Pharmaceuticals, Inc. advertising expense for fiscal 2014 was $114.42K, a 53.77% decline from fiscal 2013.
| Period end | Advertising Expense 12 month | Advertising Expense 12 month as first filed |
|---|---|---|
| 2017-12-31 | $135.00 10-K · filed 2018-04-16 | |
| 2016-12-31 | $3.85K 10-K · filed 2018-04-16 | $69.00 10-K · filed 2017-09-25 |
| 2015-12-31 | $25.43K 10-K · filed 2017-09-25 | |
| 2014-12-31 | $114.42K 10-K · filed 2017-06-19 | $90.11K 10-K · filed 2015-04-14 |
| 2013-12-31 | $247.50K 10-K · filed 2015-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |